Harvard Psychopharmacology 2025: A Master Class

• Target Audience: psychiatrists and other physicians, pharmacists
• Sample video: contact me for sample video
• Information:

2025 Course Overview

We are pleased to offer our 14th annual two-day Master Class uniquely designed for practicing clinicians, clinical researchers, and trainees in psychiatry. Presentations will focus on typical psychiatric patients with emphasis on those who are difficult to treat or are treatment resistant. Newer treatments and developing treatment strategies will be discussed including the use of genetic tests, blood level measurements, and drug combinations. New research that can inform clinical practice will be emphasized. There will be considerable opportunity for interaction with the presenters.

Throughout the course both the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications as well as new neurobiological research findings that will influence clinical practice.

Who Should Attend

Psychiatrists and other Physicians

Pharmacists

Nurse Practitioners

Physician Assistants

Nurses

Psychologists

Social Workers

Medical students, residents and other trainees

Learning Objectives

Upon completion of this activity, participants will be able to:

Evaluate the effects of neurotransmitters, neurocircuits, and genes on psychotropic drug treatment.

Outline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress, and anxiety, PTSD, and neuropsychiatric disorders.

Discuss the role of psychopharmacology in the management of depression and bipolar disorder in childhood and adolescence.

Identify the benefits and risks of ketamine and psychedelics, including use for PTSD.

Discuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period.

Explain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis.

Give examples of the latest advances and problems associated with treatment approaches in the geriatric populations.

• Topics:

Friday, March 28, 2025

Saturday, March 29, 2025